Protagonist Therapeutics Files Q1 2025 10-Q
Ticker: PTGX · Form: 10-Q · Filed: May 6, 2025 · CIK: 1377121
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Protagonist Therapeutics filed its Q1 2025 10-Q. Financials look stable.
AI Summary
Protagonist Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operational updates. Key financial figures such as retained earnings, additional paid-in capital, and accumulated other comprehensive income are reported for various periods, including March 31, 2025, December 31, 2024, and March 31, 2024.
Why It Matters
This 10-Q filing provides investors with an update on Protagonist Therapeutics' financial health and performance for the first quarter of 2025, crucial for understanding the company's current standing.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact news.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-06 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Protagonist Therapeutics, Inc. (company) — Filer of the 10-Q
- 0001377121 (company) — Central Index Key for Protagonist Therapeutics, Inc.
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date
FAQ
What is the total amount of Additional Paid-In Capital as of March 31, 2025?
The filing indicates 'us-gaap:AdditionalPaidInCapitalMember' for 2025-03-31, but the specific dollar amount is not provided in this snippet.
What was the company's Retained Earnings balance on December 31, 2024?
The filing lists 'us-gaap:RetainedEarningsMember' for 2024-12-31, but the exact value is not present in the provided text.
What is the fiscal year end for Protagonist Therapeutics, Inc.?
The fiscal year end for Protagonist Therapeutics, Inc. is December 31 (1231).
When was Protagonist Therapeutics, Inc. incorporated?
The state of incorporation for Protagonist Therapeutics, Inc. is Delaware (DE).
What is the SIC code for Protagonist Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Protagonist Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Protagonist Therapeutics, Inc (PTGX).